CA
54
10
UHS
56
-6
PNC
64
8
PCAR
50
5
URBN
59
3
SLG
37
-8
SIG
47
6
DVA
63
2
NWSA
73
4
HPE
46
17
FRT
39
-11
DFS
64
-3
UAL
61
4
CTAS
56
4
BAC
66
4
MCHP
46
3
EL
27
-3
VTR
60
2
CCI
46
2
SWK
48
2
CA
54
10
UHS
56
-6
PNC
64
8
PCAR
50
5
URBN
59
3
SLG
37
-8
SIG
47
6
DVA
63
2
NWSA
73
4
HPE
46
17
FRT
39
-11
DFS
64
-3
UAL
61
4
CTAS
56
4
BAC
66
4
MCHP
46
3
EL
27
-3
VTR
60
2
CCI
46
2
SWK
48
2
Financhill
Back

John Hancock Financial Opportunities Fund Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
46

BTO
John Hancock Financial Opportunities Fund

Last Price:
$35.66
Seasonality Move:
0.57%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$106.83
Seasonality Move:
8.04%
Sell
46
John Hancock Financial Opportunities Fund (BTO) is a Sell

Is John Hancock Financial Opportunities Fund a Buy, Sell or Hold?

  • The current John Hancock Financial Opportunities Fund [BTO] share price is $35.65. The Score for BTO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BTO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BTO Stock Price Chart

What is John Hancock Financial Opportunities Fund's stock price today?

  • The John Hancock Financial Opportunities Fund share price today is $35.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTO is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $106.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

BTO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 39.56 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.18 - 37.9) Sell
Bollinger Bands (100): (34.22 - 38.16) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.25 Sell
Relative Strength Index (14 RSI): 41.97 Sell
Chaikin Money Flow: 469170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.93 - 115.87) Sell
Bollinger Bands (100): (111.92 - 127.28) Sell

BTO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.13 Sell
20-day SMA: 37.02 Sell
50-day SMA: 36.3 Sell
200-day SMA: 33.25 Buy
8-day EMA: 35.97 Sell
20-day EMA: 36.53 Sell
50-day EMA: 36.55 Sell
200-day EMA: 34.04 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.35 Buy
20-day SMA: 109.97 Sell
50-day SMA: 116.57 Sell
200-day SMA: 127.54 Sell
8-day EMA: 106.76 Buy
20-day EMA: 109.7 Sell
50-day EMA: 114.67 Sell
200-day EMA: 122.08 Sell

John Hancock Financial Opportunities Fund Earnings Growth & BTO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.

John Hancock Financial Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):